| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |